Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-38,438
Closed -$3.39M 1853
2026
Q1
$3.39M Buy
+38,438
New +$3.12M 0.03% 570
2025
Q3
Sell
-74,795
Closed -$10.9M 1815
2025
Q2
$10.9M Buy
74,795
+63,570
+566% +$9.2M 0.1% 212
2025
Q1
$1.42M Sell
11,225
-43,332
-79% -$5.48M 0.01% 822
2024
Q4
$5.67M Buy
+54,557
New +$5.19M 0.04% 413
2024
Q3
Sell
-28,430
Closed -$2M 1881
2024
Q2
$2M Buy
28,430
+2,130
+8% +$142K 0.01% 778
2024
Q1
$1.66M Sell
26,300
-18,619
-41% -$1.12M 0.01% 778
2023
Q4
$2.67M Buy
44,919
+24,509
+120% +$1.34M 0.02% 494
2023
Q3
$919K Buy
20,410
+485
+2% +$19.7K 0.01% 991
2023
Q2
$742K Buy
+19,925
New +$797K 0.01% 1214
2022
Q3
Sell
-12,231
Closed -$499K 2115
2022
Q2
$499K Sell
12,231
-10,493
-46% -$389K 0.01% 1350
2022
Q1
$826K Buy
+22,724
New +$754K 0.01% 1266
2021
Q4
Sell
-128,809
Closed -$4.63M 2419
2021
Q3
$4.63M Buy
128,809
+69,155
+116% +$2.27M 0.06% 426
2021
Q2
$1.92M Sell
59,654
-46,107
-44% -$1.37M 0.02% 705
2021
Q1
$3.18M Buy
105,761
+27,765
+36% +$721K 0.05% 410
2020
Q4
$1.66M Sell
77,996
-102,817
-57% -$2.55M 0.02% 622
2020
Q3
$4.76M Buy
180,813
+171,333
+1,807% +$6.63M 0.09% 185
2020
Q2
$258K Buy
+9,480
New +$228K 0.01% 1388

Other funds holding LRN

Michael Gelband's LRN Position: Q2 2026 in Review

Michael Gelband sold out of Stride (LRN) in Q2 2026, closing a stake of 38,438 shares — an estimated $3.39M sold.

Michael Gelband first reported a position in LRN in Q2 2020 and held it in 17 quarters. The position peaked at $10.9M in Q2 2025. 410 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • Michael Gelband reported no remaining Stride position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 38,438 Stride shares in Q2 2026, an estimated $3.39M.
  • Michael Gelband first reported a position in Stride in Q2 2020 and held it in 17 quarters.
  • Michael Gelband's Stride position peaked at $10.9M in Q2 2025.
  • 410 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.